MR-3066

N/A

Report date: 2023/05/17 08:52:00

Base Information

Drug NameMR-3066
Drug Alias NameMP-3066IP-301
ClassificationOther
Mechanisms of ActionAcetylcholine release inhibitor
TargetsNot applicable
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedea Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedea Research
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A